Key facts
- INDV - Indivior Pharmaceuticals, Inc. has 13 insiders with reported activity on this page.
- Net insider value flow over the last year: +$203,608.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 13 Insiders of Indivior Pharmaceuticals, Inc.
- Symbol
- INDV on Nasdaq
- Location
- North Chesterfield, VA
Change
- Buy value: $203,608; sell value: $0.
- Net share flow: +5,850.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$203,608.
Buys
$203,608
Shares: 5,850
Insiders: 6
Sells
$0
Shares: 0
Insiders: 0
Net
+$203,608
Shares: +5,850
Insiders: 6
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 979 | 0 | $31,211 | $0 | +$31,211 |
| 3-6 | 4,871 | 0 | $172,397 | $0 | +$172,397 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Indivior Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Ryan Preblick | Chief Financial Officer | $10,575,160 | Market | 14 Mar 2026 | ||
| Christian Heidbreder | Chief Scientific Officer | $8,127,401 | Market | 03 Mar 2026 | ||
| Joseph Ciaffoni | Chief Executive Officer, Director | $4,623,184 | Mixed | 10 Feb 2026 | ||
| Jeffrey W. Burris | Chief Legal Officer | $2,357,948 | Market | 03 Mar 2026 | ||
| Patrick A. Barry | Chief Commercial Officer | $1,066,920 | Mixed | 10 Feb 2026 | ||
| David E. Wheadon | Director | $993,575 | +$62,680 | +6.7% | Mixed | 13 May 2026 |
| Daniel A. Ninivaggi | Director | $876,818 | +$27,429 | +3.2% | Mixed | 13 May 2026 |
| Mark Stejbach | Director | $874,365 | +$27,429 | +3.2% | Mixed | 13 May 2026 |
| Woodrow D. Anderson | Chief Accounting Officer | $812,314 | Market | 03 Mar 2026 | ||
| Juliet Thompson | Director | $605,183 | Mixed | 12 May 2026 | ||
| Keith Humphreys | Director | $517,834 | +$27,429 | +5.6% | Mixed | 13 May 2026 |
| Barbara Ryan | Director | $395,170 | +$28,687 | +7.8% | Mixed | 13 May 2026 |
| Stuart A. Kingsley | Director | $390,586 | +$29,953 | +8.3% | Mixed | 13 May 2026 |
Top shareholders of Indivior Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
14%
|
17,806,183
|
$638,884,065 | +$335,082,637 | 31 Dec 2025 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
13F
|
Vanguard Portfolio Management · Company |
6.6%
|
7,994,836
|
$272,463,211 | $0 | 31 Mar 2026 | |
| Oaktree Capital Holdings, LLC |
13D/G
|
— |
5.7%
|
7,108,664
|
$232,808,746 | -$53,592,755 | 24 Dec 2025 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Vanguard Capital Management · Company |
5.4%
|
6,523,720
|
$222,327,725 | $0 | 31 Mar 2026 | |
| Two Seas Capital LP |
13D/G
13F
|
Company |
5%
|
6,211,854
|
$203,438,218 | -$27,837,500 | 23 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
3.8%
|
4,806,556
|
$158,472,151 | +$77,320,782 | 17 Mar 2026 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13D/G
13F
|
Company |
3.7%
|
4,529,583
|
$146,214,501 | -$59,457,962 | 31 Mar 2026 | |
| James E. Flynn |
13D/G
|
Deerfield Mgmt, L.P. |
3.7%
|
4,614,498
|
$111,255,547 | -$143,518,681 | 10 Nov 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
3.7%
from 13D/G
|
3,505,817
|
$106,857,302 | — | 31 Mar 2026 | |
| Madison Avenue Partners, LP |
13D/G
13F
|
Madison Avenue International LP · Company |
3.5%
|
4,315,162
|
$139,292,998 | -$63,440,979 | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13D/G
13F
|
THE GOLDMAN SACHS GROUP, INC. · Company |
2.9%
|
3,592,431
|
$122,142,647 | -$99,940,892 | 31 Dec 2025 | |
| Ryan Preblick |
3/4/5
|
Chief Financial Officer |
0.26%
|
320,751
|
$10,575,160 | — | 14 Mar 2026 | |
| Christian Heidbreder |
3/4/5
|
Chief Scientific Officer |
0.2%
|
246,509
|
$8,127,401 | — | 03 Mar 2026 | |
| Joseph Ciaffoni |
3/4/5
|
Chief Executive Officer, Director |
0.11%
|
135,976
|
$4,623,184 | — | 10 Feb 2026 | |
| Jeffrey W. Burris |
3/4/5
|
Chief Legal Officer |
0.06%
|
71,518
|
$2,357,948 | — | 03 Mar 2026 | |
| Patrick A. Barry |
3/4/5
|
Chief Commercial Officer |
0.03%
|
31,380
|
$1,066,920 | — | 10 Feb 2026 | |
| David E. Wheadon |
3/4/5
|
Director |
0.02%
|
30,780
|
$993,575 | +$62,680 | 13 May 2026 | |
| Daniel A. Ninivaggi |
3/4/5
|
Director |
0.02%
|
27,163
|
$876,818 | +$27,429 | 13 May 2026 | |
| Mark Stejbach |
3/4/5
|
Director |
0.02%
|
27,087
|
$874,365 | +$27,429 | 13 May 2026 | |
| Woodrow D. Anderson |
3/4/5
|
Chief Accounting Officer |
0.02%
|
24,638
|
$812,314 | — | 03 Mar 2026 | |
| Juliet Thompson |
3/4/5
|
Director |
0.02%
|
18,748
|
$605,183 | — | 12 May 2026 | |
| Keith Humphreys |
3/4/5
|
Director |
0.01%
|
16,042
|
$517,834 | +$27,429 | 13 May 2026 | |
| Barbara Ryan |
3/4/5
|
Director |
0.01%
|
12,242
|
$395,170 | +$28,687 | 13 May 2026 | |
| Stuart A. Kingsley |
3/4/5
|
Director |
0.01%
|
12,100
|
$390,586 | +$29,953 | 13 May 2026 | |
| Gotham Asset Management, LLC |
13F
|
Company |
0.14%
|
171,475
|
$5,226,558 | — | 31 Mar 2026 | |
| KLP KAPITALFORVALTNING AS |
13F
|
Company |
0.03%
|
42,626
|
$1,299,240 | — | 31 Mar 2026 | |
| OAKTREE CAPITAL MANAGEMENT LP |
13F
|
Company |
—
class O/S missing
|
6,984,102
|
$212,875,428 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
4,903,993
|
$149,473,707 | — | 31 Mar 2026 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
3,574,044
|
$108,936,861 | — | 31 Mar 2026 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
—
class O/S missing
|
3,097,790
|
$94,420,639 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
2,925,688
|
$89,194,249 | — | 31 Mar 2026 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
—
class O/S missing
|
2,742,434
|
$83,589,388 | — | 31 Mar 2026 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
—
class O/S missing
|
2,323,264
|
$70,813,087 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
2,192,264
|
$66,820,207 | — | 31 Mar 2026 | |
| Newtyn Management, LLC |
13F
|
Company |
—
class O/S missing
|
2,000,000
|
$60,960,000 | — | 31 Mar 2026 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
1,880,039
|
$57,303,589 | — | 31 Mar 2026 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
—
class O/S missing
|
1,835,100
|
$55,933,848 | — | 31 Mar 2026 | |
| BARCLAYS PLC |
13F
|
Company |
—
class O/S missing
|
1,745,751
|
$53,210,489 | — | 31 Mar 2026 | |
| Invesco Ltd. |
13F
|
Company |
—
class O/S missing
|
1,561,763
|
$47,602,535 | — | 31 Mar 2026 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
1,391,612
|
$42,393,000 | — | 31 Mar 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
—
class O/S missing
|
1,332,128
|
$40,591,049 | — | 31 Mar 2026 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
—
class O/S missing
|
1,274,000
|
$38,831,520 | — | 31 Mar 2026 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
—
class O/S missing
|
1,217,721
|
$37,116,136 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
1,161,403
|
$35,399,564 | — | 31 Mar 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
—
class O/S missing
|
1,141,885
|
$34,804,655 | — | 31 Mar 2026 | |
| Jeffrey L. Gendell |
13F
|
Individual |
—
class O/S missing
|
1,096,343
|
$33,416,535 | — | 31 Mar 2026 | |
| Nuveen, LLC |
13F
|
Company |
—
class O/S missing
|
930,911
|
$28,374,167 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
—
class O/S missing
|
858,176
|
$26,157,204 | — | 31 Mar 2026 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
—
class O/S missing
|
828,891
|
$25,264,598 | — | 31 Mar 2026 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
—
class O/S missing
|
767,378
|
$23,389,682 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for Indivior Pharmaceuticals, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Juliet Thompson | INDV | Common Stock | Award | 101% | 6,518 | 12,973 | 13 May 2026 | Direct | ||
| Keith Humphreys | INDV | Common Stock | Award | 68.4% | 6,518 | 16,042 | 13 May 2026 | Direct | ||
| Stuart A. Kingsley | INDV | Common Stock | Award | 116.8% | 6,518 | 12,100 | 13 May 2026 | Direct | ||
| Daniel A. Ninivaggi | INDV | Common Stock | Award | 31.6% | 6,518 | 27,163 | 13 May 2026 | Direct | ||
| Barbara Ryan | INDV | Common Stock | Award | 113.9% | 6,518 | 12,242 | 13 May 2026 | Direct | ||
| Mark Stejbach | INDV | Common Stock | Award | 31.7% | 6,518 | 27,087 | 13 May 2026 | Direct | ||
| David E. Wheadon | INDV | Common Stock | Award | 51.2% | 10,430 | 30,780 | 13 May 2026 | Direct | ||
| Juliet Thompson | INDV | Common Stock | Tax liability | -14.8% | -1,117 | 6,455 | 12 May 2026 | Direct | ||
| Ryan Preblick | INDV | Common Stock | Tax liability | -0.88% | -2,843 | 320,751 | 14 Mar 2026 | Direct | ||
| Ryan Preblick | INDV | Common Stock | Options Exercise | 1.99% | 6,302 | 323,594 | 14 Mar 2026 | Direct | ||
| Ryan Preblick | INDV | Restricted Stock Units | Options Exercise | -100% | -6,302 | 0 | 14 Mar 2026 | Direct | ||
| Barbara Ryan | INDV | Common Stock | Purchase | 0.14% | $249 | $31.08 | 8 | 5,724 | 13 Mar 2026 | Direct |
| Barbara Ryan | INDV | Common Stock | Purchase | 0.55% | $1,009 | $32.56 | 31 | 5,716 | 09 Mar 2026 | Direct |
| Stuart A. Kingsley | INDV | Common Stock | Purchase | 20.2% | $29,953 | $31.86 | 940 | 5,582 | 06 Mar 2026 | Direct |
| Woodrow D. Anderson | INDV | Common Stock | Tax liability | -33.9% | -10,965 | 21,374 | 03 Mar 2026 | Direct | ||
| Woodrow D. Anderson | INDV | Common Stock | Options Exercise | 454.6% | 24,310 | 29,657 | 03 Mar 2026 | Direct | ||
| Woodrow D. Anderson | INDV | Restricted Stock Units | Options Exercise | -100% | -5,946 | 0 | 03 Mar 2026 | Direct | ||
| Woodrow D. Anderson | INDV | Performance Stock Units | Options Exercise | -100% | -23,975 | 0 | 03 Mar 2026 | Direct | ||
| Ryan Preblick | INDV | Common Stock | Options Exercise | 37.8% | 86,949 | 317,292 | 03 Mar 2026 | Direct | ||
| Ryan Preblick | INDV | Common Stock | Tax liability | -27.6% | -87,597 | 230,343 | 03 Mar 2026 | Direct | ||
| Ryan Preblick | INDV | Performance Stock Units | Options Exercise | -100% | -113,510 | 0 | 03 Mar 2026 | Direct | ||
| Jeffrey W. Burris | INDV | Common Stock | Tax liability | -33.5% | -36,032 | 71,518 | 03 Mar 2026 | Direct | ||
| Jeffrey W. Burris | INDV | Common Stock | Options Exercise | 288.9% | 79,893 | 107,550 | 03 Mar 2026 | Direct | ||
| Jeffrey W. Burris | INDV | Performance Stock Units | Options Exercise | -100% | -104,300 | 0 | 03 Mar 2026 | Direct | ||
| Christian Heidbreder | INDV | Common Stock | Tax liability | -15.7% | -45,797 | 246,509 | 03 Mar 2026 | Direct | ||
| Christian Heidbreder | INDV | Common Stock | Options Exercise | 53.2% | 101,544 | 292,306 | 03 Mar 2026 | Direct | ||
| Christian Heidbreder | INDV | Performance Stock Units | Options Exercise | -100% | -132,565 | 0 | 03 Mar 2026 | Direct | ||
| Woodrow D. Anderson | INDV | Common Stock | Award | 157.2% | 6,903 | 11,293 | 10 Feb 2026 | Direct | ||
| Ryan Preblick | INDV | Common Stock | Award | 13.3% | 37,358 | 317,940 | 10 Feb 2026 | Direct | ||
| Jeffrey W. Burris | INDV | Common Stock | Award | 3539.1% | 26,897 | 27,657 | 10 Feb 2026 | Direct | ||
| Christian Heidbreder | INDV | Common Stock | Award | 21.4% | 33,622 | 190,762 | 10 Feb 2026 | Direct | ||
| Patrick A. Barry | INDV | Common Stock | Award | 31,380 | 31,380 | 10 Feb 2026 | Direct | |||
| Joseph Ciaffoni | INDV | Common Stock | Award | 142.8% | 79,976 | 135,976 | 10 Feb 2026 | Direct | ||
| Woodrow D. Anderson | INDV | Performance Stock Units | Award | 23,975 | 23,975 | 09 Feb 2026 | Direct | |||
| Ryan Preblick | INDV | Performance Stock Units | Award | 113,510 | 113,510 | 09 Feb 2026 | Direct | |||
| Jeffrey W. Burris | INDV | Performance Stock Units | Award | 104,300 | 104,300 | 09 Feb 2026 | Direct | |||
| Christian Heidbreder | INDV | Performance Stock Units | Award | 132,565 | 132,565 | 09 Feb 2026 | Direct | |||
| Keith Humphreys | INDV | Common Stock | Award | 64.2% | 3,722 | 9,524 | 26 Jan 2026 | Direct | ||
| Barbara Ryan | INDV | Common Stock | Award | 189.6% | 3,722 | 5,685 | 26 Jan 2026 | Direct | ||
| David E. Wheadon | INDV | Common Stock | Award | 41.4% | 5,955 | 20,350 | 26 Jan 2026 | Direct | ||
| Juliet Thompson | INDV | Common Stock | Award | 96.7% | 3,722 | 7,572 | 26 Jan 2026 | Direct | ||
| Mark Stejbach | INDV | Common Stock | Award | 22.1% | 3,722 | 20,569 | 26 Jan 2026 | Direct | ||
| Stuart A. Kingsley | INDV | Common Stock | Award | 404.6% | 3,722 | 4,642 | 26 Jan 2026 | Direct | ||
| Daniel A. Ninivaggi | INDV | Common Stock | Award | 22% | 3,722 | 20,645 | 26 Jan 2026 | Direct | ||
| Barbara Ryan | INDV | Ordinary Shares | Purchase | 65.2% | $27,429 | $35.39 | 775 | 1,963 | 05 Jan 2026 | Direct |
| Keith Humphreys | INDV | Ordinary Shares | Purchase | 15.4% | $27,429 | $35.39 | 775 | 5,802 | 05 Jan 2026 | Direct |
| Daniel A. Ninivaggi | INDV | Ordinary Shares | Purchase | 4.8% | $27,429 | $35.39 | 775 | 16,923 | 05 Jan 2026 | Direct |
| Mark Stejbach | INDV | Ordinary Shares | Purchase | 4.82% | $27,429 | $35.39 | 775 | 16,847 | 05 Jan 2026 | Direct |
| David E. Wheadon | INDV | Ordinary Shares | Purchase | 14% | $62,680 | $35.39 | 1,771 | 14,395 | 05 Jan 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.